Pharmaceuticals: Major
Austrian companies operating in the same pharmaceuticals: major industry
The table below has Austrian companies that operate under the same industry, pharmaceuticals: major. This list helps you analyze each company’s performance, income statements, and stock activity — all in one place. Sort by key metrics to find the most expensive stocks like Eli Lilly and Company, or spot the most traded options, such as Novo Nordisk A/S Class B. Ideal for investors and traders looking to build or refine a strategy within this growing tech segment.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 LLYCEli Lilly and Company | 990.15 B EUR | 1,052.4 EUR | +0.92% | 36 | 0.80 | 43.77 | 24.05 EUR | +115.50% | 0.54% | Health technology | Buy |
 JNJJohnson & Johnson | 558.01 B EUR | 230.85 EUR | +1.05% | 0 | 0.00 | 30.56 | 7.55 EUR | −4.82% | 1.99% | Health technology | Buy |
 ABBVAbbVie, Inc. | 402.82 B EUR | 227.6 EUR | +0.35% | 0 | — | 129.70 | 1.75 EUR | −19.05% | 2.60% | Health technology | Buy |
 ROGPRoche Holding Ltd | 304.55 B EUR | 382 EUR | +1.06% | 0 | 0.00 | 23.01 | 16.60 EUR | +32.10% | 2.76% | Health technology | Buy |
| ROGHRoche Holding Ltd | 304.55 B EUR | 387.6 EUR | +0.94% | 0 | — | 23.35 | 16.60 EUR | +32.10% | 3.00% | Health technology | Buy |
 MRKMerck & Co., Inc. | 284.57 B EUR | 115.20 EUR | +0.33% | 341 | 1.22 | 37.46 | 3.08 EUR | −51.56% | 2.56% | Health technology | Buy |
 NOVNNovartis AG | 249.27 B EUR | 136.42 EUR | −0.64% | 0 | — | 23.96 | 5.69 EUR | −10.40% | 2.92% | Health technology | Neutral |
 NNO2Novo Nordisk A/S Class B | 189.65 B EUR | 42.965 EUR | +0.82% | 17.1 K | 1.33 | 11.74 | 3.66 EUR | +16.55% | 3.65% | Health technology | Buy |
 PFEPfizer Inc. | 122.95 B EUR | 21.615 EUR | −1.44% | 2.96 K | 2.60 | 19.15 | 1.13 EUR | −11.40% | 7.01% | Health technology | Neutral |
 BMYSBristol-Myers Squibb Company | 111.46 B EUR | 54.55 EUR | +0.50% | 0 | — | 17.69 | 3.08 EUR | +25.24% | 4.03% | Health technology | Buy |
 VRTXVertex Pharmaceuticals Incorporated | 106.51 B EUR | 421.05 EUR | +0.73% | 0 | 0.00 | 28.84 | 14.60 EUR | — | 0.00% | Health technology | Buy |
 SANOSanofi SA | 91.68 B EUR | 76.09 EUR | +0.03% | 1.02 K | 4.64 | 17.88 | 4.26 EUR | −3.87% | 5.42% | Health technology | Buy |
 MRCKMerck KGaA | 60.5 B EUR | 139.90 EUR | +0.11% | 0 | 0.00 | 24.02 | 5.82 EUR | −10.15% | 1.58% | Health technology | Buy |
 REGNRegeneron Pharmaceuticals, Inc. | 60.46 B EUR | 582.3 EUR | +1.52% | 0 | 0.00 | 16.39 | 35.52 EUR | −2.18% | 0.55% | Health technology | Buy |
 TKDTakeda Pharmaceutical Co. Ltd. | 48.36 B EUR | 30.58 EUR | +4.37% | 0 | — | — | −0.53 EUR | −230.42% | 3.54% | Health technology | Buy |
 UCBUCB S.A. | 46.74 B EUR | 245.1 EUR | +2.08% | 0 | 0.00 | 30.55 | 8.02 EUR | +46.56% | 0.41% | Health technology | Buy |
 BAYNBayer AG | 45.25 B EUR | 46.16 EUR | −0.17% | 1.08 K | 0.64 | — | −2.19 EUR | +33.72% | 0.24% | Health technology | Buy |
 GALDGalderma Group AG | 43.88 B EUR | 186 EUR | +1.64% | 0 | 0.00 | 59.13 | 3.15 EUR | +113.32% | 0.20% | Health technology | Buy |
 SDZSandoz Group Ltd | 30.12 B EUR | 68.74 EUR | −1.04% | 0 | 0.00 | 37.05 | 1.86 EUR | +36,240.15% | 1.26% | Health technology | Buy |
 ZOTSZoetis, Inc. Class A | 27.77 B EUR | 66.08 EUR | +0.79% | 0 | — | 12.65 | 5.22 EUR | +1.50% | 2.73% | Health technology | Buy |
 BIIBBiogen Inc. | 26.24 B EUR | 177.86 EUR | −0.44% | 0 | 0.00 | 22.05 | 8.07 EUR | −13.83% | 0.00% | Health technology | Buy |
 VTRSViatris, Inc. | 17.79 B EUR | 15.146 EUR | +3.51% | 0 | 0.00 | — | −0.22 EUR | +92.37% | 2.78% | Health technology | Buy |
 IPNIpsen SA | 13.1 B EUR | 158.5 EUR | −1.92% | 0 | 0.00 | 29.80 | 5.32 EUR | +28.24% | 1.01% | Health technology | Buy |
 RECRecordati S.p.A. | 10.6 B EUR | 51.40 EUR | 0.00% | 0 | — | 22.79 | 2.26 EUR | +12.81% | 2.61% | Health technology | Buy |
 KRKGKrka, d. d., Novo mesto | 8.15 B EUR | 265.0 EUR | −0.19% | 0 | — | 19.25 | 13.77 EUR | +10.70% | 3.15% | Health technology | Buy |
 ALKBALK-abello A/S Class B | 6.74 B EUR | 30.50 EUR | +0.20% | 0 | — | 39.56 | 0.77 EUR | +36.09% | 0.70% | Health technology | Strong buy |
 GRFGrifols, S.A. Class A | 5.8 B EUR | 9.602 EUR | +1.98% | 0 | — | 15.73 | 0.61 EUR | +112.68% | 1.95% | Health technology | Buy |
 LUNAH. Lundbeck A/S Class A | 4.46 B EUR | 4.845 EUR | −0.21% | 0 | 0.00 | 9.74 | 0.50 EUR | +12.05% | 3.19% | Health technology | No rating |
| LUNBH. Lundbeck A/S Class B | 4.46 B EUR | 5.655 EUR | −0.09% | 0 | 0.00 | 11.36 | 0.50 EUR | +12.05% | 2.73% | Health technology | Buy |
 SFZNSiegfried Holding AG | 3.43 B EUR | 75.90 EUR | −0.20% | 0 | 0.00 | 18.36 | 4.13 EUR | +5.42% | 0.57% | Health technology | Buy |
 ROVILaboratorios Farmaceuticos Rovi, S.A. | 2.97 B EUR | 59.10 EUR | +0.68% | 0 | — | 16.32 | 3.62 EUR | +39.34% | 1.29% | Health technology | Buy |
 ALMAlmirall SA | 2.44 B EUR | 11.38 EUR | +2.52% | 0 | — | 52.76 | 0.22 EUR | — | 1.35% | Health technology | Strong buy |
 DMPDermapharm Holding SE | 2 B EUR | 40.40 EUR | −0.86% | 0 | 0.00 | 15.08 | 2.68 EUR | +39.24% | 2.18% | Health technology | Buy |
 COPNCosmo Pharmaceuticals NV | 1.15 B EUR | 69.9 EUR | −5.67% | 679 | 16.01 | — | −0.38 EUR | −111.41% | 3.04% | Health technology | Strong buy |
 FYBFormycon AG | 333.66 M EUR | 18.78 EUR | +0.43% | 0 | — | — | −3.66 EUR | +48.61% | 0.00% | Health technology | Strong buy |
 HPHAHeidelberg Pharma AG | 123.98 M EUR | 2.56 EUR | −0.39% | 0 | — | — | −0.71 EUR | −41.49% | 0.00% | Health technology | Strong buy |
 PTPNPentixapharm Holding AG | 72.67 M EUR | 2.04 EUR | −0.49% | 0 | 0.00 | — | — | — | 0.00% | Health technology | Strong buy |
 MARIMarinomed Biotech AG | 13.8 M EUR | 6.00 EUR | 0.00% | 1.55 K | 0.39 | 0.59 | 10.15 EUR | — | 0.00% | Health technology | No rating |